// Biotech and Pharma Therapeutics AbbVie sends SHP2 deal back to port, following Big Pharma peer in retreating from target July 5, 2023 / Jacobio / AbbVie / Solid Tumor / Licensing Deals China-headquartered Jacobio has announced the termination of...